Clinical Investigator Receives Warning Letter Over Protocol and IRB Approval Lapse

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Clinical Investigator Receives Warning Letter Over Protocol and IRB Approval Lapse

J.W. Schomisch

January 10, 2024 at 10:06 AM EST

A clinical investigator at Children's Hospital of Michigan in Detroit received a Warning Letter for allegedly failing to follow study protocol and having lapsed institutional review board (IRB) approval. According to the Dec. 19 Warning Letter, clinical investigator Dr. Jeffrey Taub failed to ensure that the investigation was conducted according to the investigational plan (2... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Clinical Investigator Receives Warning Letter Over Protocol and IRB Approval Lapse

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT